AUMENTO GENGIVAL MEDICAMENTOSO
1MEDICAMENT GENGIVAL OVERGROWTH
Cezar Hubner Perez
2, Fabricio Batistin Zanatta
3, Daniel Meyne Flores
4, Silvia Ataide Pithan
4, Gustavo Nogara Dotto
4e Ana Maria
Chagas
4RESUMO
2VDXPHQWRVJHQJLYDLVLQGX]LGRVSRUGURJDVVmRXPDUHVSRVWDH[DFHUEDGD GR WHFLGR JHQJLYDO TXH FDXVDP GHVFRQIRUWR HVWpWLFR IXQFLRQDO H ¿VLROyJLFR DR SDFLHQWH 'HQWUH RV PHGLFDPHQWRV GH XVR VLVWrPLFR TXH FDXVDP WDO HIHLWR FRODWHUDOHVWmRRVLPXQRVVXSUHVVRUHVRVDQWLFRQYXOVLYDQWHVHRVEORTXHDGRUHV GRVFDQDLVGHFiOFLR'RSRQWRGHYLVWDFOtQLFRHKLVWRSDWROyJLFRDVPXGDQoDV JHQJLYDLVSURYRFDGDVSRUHVVHVWUrVJUXSRVVmRPXLWRVLPLODUHVHQWUHWDQWRD SUHYDOrQFLDGDDOWHUDomRQRVWUrVJUXSRVpGLIHUHQWH2REMHWLYRQHVWHHVWXGR IRLUHYLVDUDWUDYpVGHOLWHUDWXUDRVDVSHFWRVVLPLODUHVGDKLSHUSODVLDJHQJLYDO induzida por três categorias distintas de medicamentos: aspectos clínicos e KLVWRSDWROyJLFRV SUHYDOrQFLD GLDJQyVWLFR GLIHUHQFLDO H WUDWDPHQWR GD OHVmR FRQVLGHUDQGR SURSULHGDGHV LQGLFDo}HV H HIHLWRV DGYHUVRV UHODFLRQDGRV jV drogas.
Palavras-chave: hiperplasia gengival, ciclosporina, fenitoína, nifedipina.
ABSTRACT
'UXJLQGXFHGJLQJLYDORYHUJURZWKUHSUHVHQWVDQH[DFHUEDWHUHVSRQVHRI JLQJLYDOWLVVXHVWKDWUHVXOWVLQDHVWKHWLFIXQFWLRQDODQGSK\VLRORJLFXQHDVHWRWKH patient. Among the systemic medications that have been reported to cause this VLGHHIIHFWDUHF\FORVSRULQ$FDOFLXPFKDQQHOEORFNHUVDQGSKHQ\WRLQ&OLQLFDOO\
DQGKLVWRORJLFDOO\JLQJLYDOK\SHUSODVLDLQGXFHGE\WKHVHGUXJVLVYHU\VLPLODU but the prevalence of this alteration in the three groups of drugs is different.
7KHSXUSRVHRIWKLVVWXG\ZDVWRUHYLHZWKURXJKWKHVSHFLDOL]HGOLWHUDWXUHWKH similar aspects of gingival hyperplasia induced by three categories of distinct PHGLFDPHQWV FOLQLFDO DQG K\VWRSDWKRORJLFDO DVSHFWV SUHYDOHQFH GLIIHUHQWLDO GLDJQRVLVDQGWUHDWPHQWRIWKHLQMXU\FRQVLGHULQJSURSHUWLHVLQGLFDWLRQVDQG adverse effects related to these drugs.
Key words:JLQJLYDOK\SHUSODVLDF\FORVSRULQHSKHQ\WRLQQLIHGLSLQH
1 Trabalho de Iniciação Científica.
2 Acadêmico do Curso de Odontologia - UNIFRA.
3 Orientador - UNIFRA.
4 Colaboradores - UNIFRA.